Glenmede Trust CO Na Ocular Therapeutix, Inc Call Options Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OCUL
# of Institutions
172Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$145 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$128 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$128 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$84.3 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $774M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...